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Coronary artery bypass grafting (CABG) is a commonly used revascularization technique for 
coronary artery disease. In addition to traditional on-pump CABG (ONCABG) with 
cardiopulmonary bypass (CPB), the operation can be performed on a beating heart without CPB and 
with no need for cardiac arrest, a procedure often called off-pump coronary artery bypass grafting 
(OPCABG).  
Extracorporeal circulation, aortic cross-clamping and cardiac arrest in ONCABG predispose the 
body to inflammatory response, global myocardial damage, coagulation defects and ischemia-
reperfusion injury. These are associated with low blood pressure, thrombosis, hyperthermia, 
tachycardia, leukocytosis and tissue edema which all have detrimental effects on the outcome of the 
surgery. In OPCABG, these complications were initially thought to be reduced.  
 
Especially high-risk patients seem to benefit from OPCABG when compared to conventional 
ONCABG as it decreases the risk for mortality and morbidity shortly after discharging. On the 
other hand, the risk of incomplete revascularization and poor graft patency are higher in OPCABG 
procedures and reoperation is more often needed. Thus, in the long term, the benefit of OPCABG is 
not as significant. In low- and mid-risk population undergoing OPCABG no significant benefit has 
been reported. 
 
In addition to mortality, the choice between the two is an issue of financial aspect, total hospital 
stay, risk of complications and the experience of the surgeon. Significant superiority to each other is 
yet to be proven. The choice between the two methods has still to be made individually for each 
patient undergoing CABG. 
 
The purpose of this review is to search and gather literature and articles related to OPCABG, 
shortly discuss the role of it in cardiothoracic surgery, consider financial and healthcare aspects, 
compare short- and long-term outcomes and list some of the major complications of the procedure. 
Finally, there is a summary of the pros and cons, and the literature-based conclusions. 
 
Articles related to OPCABG were searched on PubMed using search keywords myocardial 
revascularization or myocardial revascularization [Mesh] in combination with OPCAB or 
OPCABG or off-pump coronary artery bypass or coronary artery bypass, off-pump [Mesh]. Also, 
some basic information such as explanations of procedures, have been cited from organization 
websites and published articles related to cardiothoracic surgery. 
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Cardiovascular disease (CVD) is the number one cause of death in the world. Three out of four 
CVD deaths occur in low- or middle-income countries. In 2016, an estimated 17,9 million people 
died because of CVDs which makes up to 31% of all deaths globally. In 85% of these deaths, the 
immediate cause was heart attack or stroke. (Cardiovascular diseases. WHO.) Coronary artery 
disease (CAD) is the most common underlying cause of death in developed countries (Caliscan et 
al. 2019). As a result, CVDs have a huge impact not only in healthcare but also in socioeconomics 
(Emelia et al. 2019). 
 
Coronary artery bypass surgery or coronary artery bypass grafting (CABG) together with coronary 
angioplasty (PCI for percutaneous coronary intervention) are the most common clinical procedures 
for myocardial revascularization (Kowalewski et al. 2016). CABG was first time used as 
myocardial infarction (MI) intervention in 1960 by Robert Goetz and Michael Rohman in the 
United States (Goetz et al. 1960). A few years later PCI was invented and then performed on a 
human almost ten years later (Mehta and Khan 2002). Both CABG and PCI are still used, although 
for the past years PCI has become more common and often used due to improved procedural 
technique and advanced stent design. Nevertheless, CABG is a rather safe revascularization 
technique that is associated with a risk of 1-2% for intraoperative mortality among elective patients 
(Halkos et al. 2008). Emergency operations increase the risk for in-hospital and early mortality. On 
the other hand, emergency and salvage CABG is often needed in cases where PCI is not suitable or 
unsuccessful. Survival rate in emergency and salvage patients is acceptable except for patients who 
received cardiac massage during the surgery. (Axelsson et al. 2016.) 
 
In CABG, the stenotic coronary artery or arteries are revascularized by blood vessels harvested 
from other parts of the body, known as grafts. Both veins and arteries can be used and have their 
advantages and disadvantages. Grafts are sutured to the target coronary arteries (surgical 
anastomoses) distally in relation to the occlusions and the normal flow of the blood is restored. The 
most common anastomosis is the left internal mammary artery (LIMA) to the left anterior 
descending artery (LAD) with supplemental grafts. (Montalescot et al. 2013). The superiority and 
safety of bilateral internal mammary artery (BIMA) compared to single internal mammary artery 






observational studies conducted in 2016. Although BIMA grafting was associated with bigger risk 
for deep sternal wound infection, the long-term survival benefit outweighs this short-term risk. 
(Buttar et al. 2017.) The radial artery has been proposed to be used instead of a second internal 
mammary artery. The long-term graft patency of arteries is generally thought to be superior 
compared with vein grafts. Despite of the superiority of the radial artery, saphenous veins remain 
the most used grafts in CABG. (Montalescot et al. 2013.)  
 
The conventional way of performing CABG is on-pump CABG (ONCABG) with cardiopulmonary 
bypass (CPB). In ONCABG the patient is connected to extracorporeal circulation (heart-lung 
machine), the aorta is clamped and the beating heart is arrested with cardioplegia solution. 
 
Another form of CABG is off-pump coronary artery bypass grafting (OPCABG) in which the 
surgeon operates on a beating heart without extracorporeal circulation and the clamping of the aorta 
can be avoided (Buffolo et al. 1985). Target coronary artery is stabilized and blood flow is stopped 
while the anastomosis is being sutured (Calafiore et al. 1998). Also, quite often a shunt is placed 
inside the target coronary artery for a better view (Yeatman et al. 2002).  
 
When comparing OPCABG and ONCABG solely on a technical aspect, the most important 
advantages of OPCABG are the avoidance of CBP and aortic manipulation since they are both 
usually followed by severe comorbidities such as renal failure, stroke, coagulation defects and 
systemic inflammatory response. These comorbidities were thought to be minimized by avoiding 
cardiac arrest, aortic cross-clamping and extracorporeal circulation. High expectations were set for 
off-pump method but its superiority compared to other surgical techniques remains unproven to this 
day. The operating technique and the difficulty to access the posterolateral wall of the heart are 
possibly the main technical disadvantages of OPCABG (Arom et al. 1999). A more detailed 
comparison between these two techniques is done in this review in terms of perioperative 












2.  RISK EVALUATION  
The European Society of Cardiology (ESC) published guidelines on the management of stable 
coronary artery disease in 2013 and then later in 2018 guidelines on myocardial revascularization 
together with the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines suggest 
that basic examination including laboratory tests, electrocardiography (ECG) and echocardiography 
at rest, cardiac magnetic resonance imaging (MRI) and ambulatory ECG known as Holter, should 
be tested when CAD is first suspected. After the patient has been diagnosed with CAD, it is 
essential to assess ischemia and the condition of the coronary arteries to identify lesions that require 
or are likely to benefit from revascularization. In addition, assessment helps finding the optimal 
drug therapy. Evaluation of the severity and stability of CAD includes both non-invasive and 
invasive examination. Non-invasive examination is recommended as the first-line testing. Invasive 
tests are recommended to carry out when findings in non-invasive examination are not enough or 
signs of severe stenosis are found. (Montalescot et al. 2013, Neumann et al. 2019.)  
Although the specificity of stress ECG in assessing the extent of ischemia is up to 90%, it is not 
recommended as the first-line test because of its poor sensitivity of 45-50%. Non-invasive 
computed tomography (CT) angiography is recommended as the first-line test due to its high 
sensitivity (95-99%) and specificity (64-83%). Assessment of myocardial viability can be achieved 
with several imaging techniques including myocardial contrast echocardiography, single-photon 
emission CT and positron emission tomography (PET). Assessment of ischemia is more critical in 
patients with mild to moderate CAD but viability assessment is more essential in patients with 
severe CAD. The condition of stenotic arteries can be examined by either fractional flow reserve 
(FFR) or with invasive CT-imaging. (Neumann et al. 2019.) 
 
The individual cardiac and extracardiac characteristics must be taken into account when choosing a 
compatible revascularization technique. These include, for example, anatomy of the heart and the 
coronary arteries, calcification of the aorta and other comorbidities. The choice has to be made in a 
multidisciplinary heart team which includes clinical cardiologists, cardiothoracic surgeons, 
interventional cardiologists and anaesthetists. Also, patient’s preferences must be taken into 









Favours PCI Favours CABG 
Severe comorbidities Diabetes 
Advanced age and reduced life expectancy Left ventricular dysfunction 
Estimation of poor rehabilitation Contraindication to antiplatelet therapy 
Anatomy that likely results in incomplete 
revascularization with CABG 
Anatomy that likely results in incomplete revascularization 
with PCI 
Severe chest deformation Severely calcified coronary artery lesions 
Porcelain aorta Need for concomitant interventions such as valve 
replacement or intervention of pathologic ascending aorta 
Table 1. Different characteristics favouring either PCI or CABG. 
 
When the decision of CABG has been made, the risk for operational complications has to be 
carefully assessed. A number of evaluation methods are globally used to calculate the risk of 
mortality for patients undergoing CABG. In Europe, European System for Cardiac Operative Risk 
Evaluation (EuroSCORE) calculator was invented in 1999 based on a dataset collected of 13 302 
patients that underwent CABG before 1995 (Nashef et al. 1999). In 2011, the EuroSCORE 
calculator was updated and calibrated to EuroSCORE II (Table 2) to better match improved 
cardiothoracic surgery outcomes since the old EuroSCORE calculator overpredicted mortality. A 
new EuroSCORE II dataset was collected over a three-month period from May to July in 2010 and 
consisted of 22 381 patients from 43 different countries and 154 units all around the world to whom 
cardiac surgery was performed. Of these, 10 448 underwent an isolated CABG. Using EuroSCORE 







Table 2. Modified EuroSCORE II calculator showing different characteristics used to assess the operative risks based on patient related, cardiac 
related and operation related factors. (Original EuroSCORE II calculator available online at http://euroscore.org/index.htm) 
CC=creatinine clearance, CCS= Canadian Cardiovascular Society, IABP=intra-aortic balloon pump, LV=left ventricular, LVEF=left ventricular 
ejection fraction, MI=myocardial infarction, NYHA=New York Heart Association. 
Patient related factors 
Age (years) 1-95  
Sex Male/female  
Renal impairment Normal (CC>85ml/min) 
Moderate (CC 50-85ml/min) 
Severe (CC<50ml/min) 
Dialysis (regardless of CC) 
Cockroft-Gault creatinine clearance (CC) calculator 
based on plasma creatinine, age, weight and sex. 
CC = (140-age (years)) x weight (kg) x (0.85 if 
female) / [72 x plasma creatinine (mg/dl)] 
Extracardiac arteriopathy No/Yes Claudication, carotid occlusion or >50% stenosis, 
amputation for arterial disease, previous or planned 
intervention on the abdominal aorta, limb arteries or 
carotids 
Poor mobility No/Yes Severe impairment of mobility secondary to 
musculoskeletal or neurological dysfunction 
Previous cardiac surgery No/Yes  
Chronic lung disease No/Yes Long term use of bronchodilators or steroids for lung 
disease 
Active endocarditis No/Yes Patient still on antibiotic treatment for endocarditis 
at time of surgery 
Critical preoperative state No/Yes Ventricular tachycardia or ventricular fibrillation or 
aborted sudden death, preoperative cardiac massage, 
preoperative ventilation before anaesthetic room, 
preoperative inotropes or IABP, preoperative acute 
renal failure (anuria or oliguria <10ml/h) 
Diabetes on insulin No/Yes  




CCS grade IV angina No/Yes Angina at rest 
LV function Good (LVEF>50%) 
Moderate (LVEF 31-50%) 
Poor (LVEF 21-30%) 
Very poor (LVEF ≤ 20%) 
 
Recent MI No/Yes Myocardial infarction within 90 days 
Pulmonary hypertension No 
Moderate (31-55mmHg) 
Severe (>55mmHg) 
Systolic pulmonary artery pressure 






Elective (routine admission for operation) 
Urgent (patients who have not been electively 
admitted for operation but who require intervention 
or surgery on the current admission for medical 
reasons. These patients cannot be sent home without 
a definitive procedure) 
Emergency (operation before the beginning of the 
next working day after decision to operate) 
Salvage (patients requiring cardiopulmonary 
resuscitation (external cardiac massage) en route to 
the operating theatre or prior to induction of 
anaesthesia. This does not include cardiopulmonary 
resuscitation following induction of anaesthesia) 





Include major interventions on the heart such as 
CABG, valve repair or replacement, replacement of 
part of the aorta, repair of a structural defect, maze 
procedure, resection of a cardiac tumour 






The New York Heart Association (NYHA) Functional Classification (Table 3) and Canadian 
Cardiovascular Society grading scale (CCS scale) (Table 4) describe the state of heart failure based 
on the symptoms and limitations during physical activities together with objective assessment.  
 
Class Patient symptoms 
I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, 
palpitation, dyspnea (shortness of breath) 
II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in 
fatigue, palpitation, dyspnea (shortness of breath). 
III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes 
fatigue, palpitation, or dyspnea. 
IV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If 
any physical activity is undertaken, discomfort increases. 
Class Objective assessment 
I No objective evidence of cardiovascular disease. No symptoms and no limitation in ordinary 
physical activity. 
II Objective evidence of minimal cardiovascular disease. Mild symptoms and slight limitation during 
ordinary activity. Comfortable at rest. 
III Objective evidence of moderately severe cardiovascular disease. Marked limitation in activity due 
to symptoms, even during less-than-ordinary activity. Comfortable only at rest. 
IV Objective evidence of severe cardiovascular disease. Severe limitations. Experiences symptoms 
even while at rest. 
Table 3. NYHA functional classification. 
The New York Heart Association (NYHA) Functional Classification describe the state of patient’s heart failure based on symptoms and 




I Ordinary physical activity does not cause angina, such as walking and climbing stairs. Angina with 
strenuous or rapid or prolonged exertion at work or recreation. 
II Slight limitation of ordinary activity. Walking or climbing stairs rapidly, walking uphill, walking or 
stair climbing after meals, or in cold, or in wind, or under emotional stress, or only during the few 
hours after awakening. Walking more than two blocks on the level and climbing more than one 
flight of ordinary stairs at a normal pace and in normal conditions 
III Marked limitation of ordinary physical activity. Walking one or two blocks on the level and 
climbing one flight of stairs in normal conditions and at normal pace. 
IV Inability to carry on any physical activity without discomfort, anginal syndrome may be present at 
rest. 
Table 4. CCS grading scale. 
Canadian Cardiovascular Society (CCS) grading scale is used together with NYHA classification to describe the state of heart failure based on 






EuroSCORE is categorized into three different categories based on the points given by the 
calculator. Patients getting score 0-2 are in low risk, 3-5 in medium risk and over 6 in high risk 
profile. (Nashef et al. 1999.) 
 
In the USA, The Society of Thoracic Surgery Risk Score (STS risk score) is preferred over 
EuroSCORE II since in addition to mortality, it predicts other severe complications and prolonged 
































3.  OPCABG TARGET GROUP 
3.1 High risk patients 
The risk profile of an OPCABG patient comprises many factors. Of these, the most remarkable ones 
are left ventricular dysfunction (LVD), highly calcified vessels, advanced age, diabetes mellitus, 
renal dysfunction, reoperations, chronic pulmonary disease, and EuroSCORE II greater than 5. 
(Kowalewski et al. 2016). In the USA, Society of Thoracic Surgeons Predicted Risk of Mortality 
(PROM) was developed to predict risk-adjusted outcomes for patients undergoing cardiothoracic 
surgery. It consists of 30 risk factors, of which most are the same as in EuroSCORE II calculator. 
The PROM score is divided into four quartiles so that the higher risk profiles are placed in the 
upper quartiles. A total of 14 766 CABG patients between 1997 and 2007 were studied in the USA. 
Of these, 7083 (48,0%) underwent OPCAB and 7683 (52,0%) CPB-assisted CABG. In the lower 
two quartiles, no intraoperative difference was observed between the two techniques. In the highest 
quartile, the death rates were 3,2% and 6,7% for OPCABG and ONCABG, respectively. (Puskas et 
al. 2009).  
3.2 Left ventricular dysfunction 
 
Ultrasound measured ejection fraction (EF) is a common measurement for left ventricular function 
(LVF). EF describes the ratio of the stroke volume to end-diastolic volume and 50-70% is 
considered normal. EF less than 50% may correlate to left ventricular dysfunction. (Kettunen 2014.) 
 
EuroSCORE II classification divides left ventricular ejection fraction (LVEF) into four different 
categories: good (LVEF 51% or more); moderate (LVEF 31-50%); poor (LVEF 21–30%) and very 
poor (LVEF 20% or less) (Nashef 2012). Patients with LVEF less than 30% undergoing primary 
and nonemergent coronary artery revascularization without CPB are associated with decreased early 
mortality and morbidity and better short-term outcomes when compared to ONCABG (Keeling et 
al. 2013, Ueki et al. 2016). Systematic literature reviews and meta-analyses have shown that      
mid- and long-term benefit is uncertain due to higher risk of incomplete revascularization in 
patients undergoing OPCABG. The need for reoperations predisposes to severe complications and 
increases the mortality rates in the long term (Jarral et al. 2011).   
 







3.3 Female sex 
 
Female sex is associated with smaller target vessels, more comorbidities and higher age at the time 
of CABG. These factors put women in higher risk for mortality and peri- and postoperative 
complications. Whether or not female gender is an independent risk factor has been a subject for 
numerous studies. (Attaran et al. 2014.) In EuroSCORE II calculator, female gender is one of the 17 
independent risk factors that increase the risk for mortality (Nashef 2012). Women carry a 
significantly higher risk for operative mortality in all categories except in very high-risk patients 
(Edwards et al. 1998). Women undergoing CABG have a 1,76 times higher risk for in-hospital 
mortality than men before adjusted to other risk factors. Even after adjusting the two sexes for the 
presence of other risk factors, mortality rates were still higher for women (4,45%) than men 
(3,33%). (Hannan et al. 1992.) OPCABG narrows the early mortality rate gap between the two 
sexes and decreases the risk for severe complications in women when compared to traditional 




Advanced age is a known risk in cardiac surgery (Nashef et al. 2012). Patients with greater age are 
usually associated with poor condition and concomitant cardiopulmonary diseases which 
understandably increase the risk for peri- and postoperative complications. In terms of in-hospital 
mortality (pooled odds ratio (OR) = 0,64; 95% confidence interval (CI) = 0.44 - 0.93; p = 0.02) and 
stroke (pooled OR = 0.61; 95% CI 0= 0.48 – 0.76; p<0.001), OPCABG provides a significantly 
safer option for conventional CABG in over 80-year-old patients. This was studied in a large 
observational meta-analysis where literature was searched from 1966 to 2016. 16 studies were 
included with 18 685 ONCABG and 8938 OPCABG patients. (Khan et al. 2017.) Risk for 
postoperative stroke for patients over 80 years was decreased (OR = 0.70; 95% CI= 0.52–0.93,       
p = 0.02) also in a comprehensive propensity analysis of 83 914 high-risk patients when compared 
with on-pump (Cavallaro et al. 2014). However, conflicting results have also been obtained. The 
German off-pump coronary artery bypass grafting in elderly patients (GOPCABE) was a 
randomized controlled trial of 2539 patients over 75 years old conducted in 12 German institutions 
between 2008 and 2011. The effect of the surgeon was minimized by including only very 
experienced CABG surgeons. The average surgery number for off-pump surgeons was 514 and 
1378 for on-pump surgeons. No significant difference between the two groups was found when 
mortality, stroke, MI, repeat revascularization or renal replacement therapy at 30 days and 12 






on-pump versus off-pump randomization study (DOORS), a randomized controlled trial of patients 
over 70 years of age, and also in a recent retrospective cohort analysis conducted in 2019 (Houlind 
et al. 2012, Parmeshwar et al. 2019). 
 
Off-pump technique in the elderly seems to pay off especially in the long term. Short-term 
outcomes of OPCABG are not as clear and the benefits seem to be clearer in terms of                 
cost-effectiveness, resource use and hospital stay. As age remains a significant risk factor for 
mortality from 60 years onward, choosing off-pump surgery for the elderly could possibly decrease 






























4.  COMPLICATIONS 
4.1 Cardiovascular complications 
 
Atrial fibrillation (AF) and atrial flutter are the most common postoperative complications in 
cardiac surgery that require intervention or prolong intensive care (ICU) and total hospital stay. The 
incidence of postoperative atrial fibrillation (POAF) is approximately 30% in patients undergoing 
an isolated CABG and 50% in those having a combination of valve replacement and CABG. The 
peak for tachyarrhythmias is between the second and fourth postoperative day and 94% of the 
incidents happen during the first week after the operation. (Mitchell 2011.) Preoperative factors that 
might predict POAF include previous AFs, advanced age, chronic renal insufficiency, the use of 
vein grafts and withdrawal of β-blocker therapy. A concomitant valve replacement, high number of 
grafts, duration of aortic cross-clamp and total procedure duration also increase the risk POAF. 
(Mitchell 2011, Vidotti et al. 2019.) CPB use does not correlate to peri- or postoperative AF and the 
occurrence of POAF is similar between OPCABG and ONCABG (Mitchell 2011). 
 
Most of the incidences are transient and symptoms vary from mild discomfort and anxiety to chest 
pain and cognitive impairment. However, AF might have detrimental consequences especially in a 
subgroup of high-risk patients. It might predispose to more adverse arrhythmias, hemodynamic 
instability and heart failure in addition to thromboembolic events including stroke. (Mitchell 2011, 
Vidotti et al. 2019.) 
 
According to Canadian cardiovascular society (CCS) guidelines, the prevention of POAF can be 
best obtained by continuing β-blocker therapy among those who have used them before the 
operation. For those who have not received prior β-blockers, therapy should be initiated just before 
or immediately after bypass surgery. Amiodarone therapy should be used for patients having         
β-blocker contraindications. (Mitchell 2011.)  
 
Although POAF treatment does not differ remarkably from the treatment of a normal AF, some 
differences in therapeutic strategies are recommended. Slowing of ventricular response should be 
treated with β-blockers and arrhythmia should be converted to sinus rhythm with cardioversion or 
drug therapy. Antithrombotic drug therapy should be initiated carefully for patients with prolonged 
AF of over 72 hours and continued for at least six weeks. Anticoagulation therapy initiated too soon 
after the occurrence of POAF might predispose to pericardial bleeding and cardiac tamponade. 







Myocardial damage that leads to heart failure occurs in 1-2% of CABG patients. Other cardiac 
complications associated with CABG include pathologic changes in ECG and bundle branch 
blocks. Cardiac enzymes, such as creatine kinase myocardial band (CK-MB) and troponin I and T 
(TnI and TnT), are commonly used tests to assess myocardial damage. However, these enzyme 
levels do not always correlate to the extent of the damage since the release of the enzymes is 
relatively small in cardiac arrest. (Ihlberg 2016.) 
 
4.2 Neurological risk 
 
Stroke is defined as an abrupt neurologic deficiency caused by cerebral blood supply disturbance 
that does not resolve within 24 hours. While stroke requires intervention, transient ischemic attack 
(TIA) is defined as a loss of neurologic function caused by cerebral blood flow disturbance that 
resolves spontaneously within 24 hours. (Halkos et al. 2008.) TIA is associated with complete 
return of normal brain function with no brain damage whereas stroke usually causes permanent 
neurological dysfunction. 
 
Stroke and TIA occurring after CABG constitute a major share of adverse outcomes that lead to 
morbidity and mortality (Mishra et al. 2006). While non-complicated CABG is considered as a safe 
revascularization method with a 1-2% risk for intraoperative mortality (Halkos et al. 2008, Ihlberg 
2016), stroke and TIA increase the risk remarkably. Overall incidence for stroke and TIA, or the 
composite of the two, after CABG was around 2% in a retrospective cohort study of 14 278 patients 
conducted between 1996 and 2006. Of these 274 incidents, 13,5% led to in-hospital death. 
Moreover, previous stroke or TIA further increase the risk for mortality. In addition to death and 
postoperative neurological complications, stroke and TIA patients are at higher risk for 
postoperative AF, renal failure and prolonged ventilation. (Halkos et al. 2008.) 
 
When compared with ONCABG, OPCABG benefits patients in terms of postoperative neurological 
events. Microembolization, inflammatory response and inconstant perfusion flow are considered to 
be the main reasons for postoperative neurological events caused by CPB. These complications can 
be minimized by avoiding the use of CPB. (Halkos et al. 2008.) 
Atheromatous aorta is the main origin of both micro- and macro-sized emboli that cause stroke and 
TIA. The condition of the aorta is an important part of clinical examination of patients undergoing 






contraindication for cross-clamping required in ONCABG. Most often, the location of atheromatous 
aorta is either in the ascending aorta or in the arch of aorta. Depending of the location, several 
surgical techniques have been invented to minimize the risk of plaque rupture resulting in stroke. 
Such techniques include no-touch technique of the ascending aorta, intra-aortic occlusion using 
balloon, long aortic cannula, prior or concomitant endarterectomy and graft replacement of the 
aorta. Moreover, intra-aortic filtration was invented to capture emboli of the atheromatous aorta. 
Although it is an effective way of capturing solid emboli with a rate of up to 97%, its role in 
preventing a stroke is minimal especially in low-risk patients. (Banbury et al. 2003). The benefit 
might be more distinct in high-risk patients. Gaseous emboli associated with open-heart surgery 
might be an explanation for adverse neurological outcomes despite the high capture rate of intra-
aortic filters. (Wimmer-Greinecker 2003.) Routine intraoperative evaluation of the aorta, such as 
transesophageal and epiaortic echocardiography, is helpful in identifying atheromatous aorta and 
could help when choosing a proper surgical technique (Mishra et al. 2004, Sharony et al. 2004, 
Mishra et al. 2006). Several studies have shown the association of OPCABG with reduced risk for 
postoperative stroke (Mishra et al. 2006, Halkos et al. 2008). 
 
Patients with severe carotid stenosis undergoing cardiac surgery are a subgroup of high-risk 
patients. 8 to 14% of CABG patients have a severe carotid artery disease and 40-50% of carotid 
endarterectomy patients have coronary artery disease. Not surprisingly, concomitant 
endarterectomy and CABG has been an interest of many cardiac surgeons. OPCABG and 
ONCABG both seem to be equally effective and safe techniques when performed together with 
carotid endarterectomy with a mortality rate of 1,6%. (Mishra et al. 2004.) 
 
In addition to stroke and TIA, patients undergoing cardiac surgery carry a higher risk for 
postoperative cognitive dysfunction (POCD) when compared to patients undergoing a non-cardiac 
surgery. Among cardiac patients, CABG is the most common cause of POCD (Kozora et al. 2010.) 
Postoperative neurological dysfunction is characterized by impairment of attention, concentration 
and memory. A large literature review of 28 relevant prospective and retrospective studies 
including 3373 patients reported contradictory results of superiority between OPCABG and 
ONCABG with regard to POCD. While early POCD occurred more often in OPCABG patients 
compared to ONCABG (50% and 31%, respectively), late outcomes were contrary (9,4% and 
26,4%, respectively). (Yuan and Lin 2019.) The incidence of delirium requiring pharmacological 






Phrenic nerve paralysis and paresis of the left recurrent laryngeal nerve or the left plexus brachial 
are rare and usually transient complications followed by surgical trauma or compression caused by 
retractors used in sternotomy (Ihlberg 2016).  
 
4.3 Acute kidney injury 
 
Chronic renal dysfunction is a common comorbidity in patients undergoing CABG (Ueki et al. 
2018). It is also a well-known risk factor for mortality as described in EuroSCORE II calculator 
(Nashef et al. 2012). Although weight and serum creatinine levels are not independent risk factors, 
they affect total creatinine clearance (CC) which in turn is an independent risk factor. Renal 
function is divided into four categories based on the CC levels. A CC level of over 85ml/min is 
considered normal, 50-85ml/min moderate and less than 50ml/min severe. Renal dysfunction 
requiring dialysis is also a sign of severely impaired renal function regardless of plasma creatinine 
levels. (Nashef et al. 2012.) 
 
Acute kidney injury (AKI) is defined by an abrupt decrease in kidney function. AKI includes, but is 
not limited to, acute renal failure. AKI leads to changes in urine output and blood chemistry which 
can have serious clinical consequences. In addition to AKI being an emergent complication on its 
own, it can also cause severe complications in other organs resulting in multiple organ failure, coma 
and death if not treated rapidly. Several factors predispose to peri- and postoperative AKI. Such risk 
factors are, for example, sepsis, a severe illness, circulatory shock and major surgeries including 
CABG. There are several diagnostic criteria for AKI. KDIGO (Kidney disease: improving global 
outcomes) is probably the most used classification globally and is based on either serum creatinine 
or urine output as listed below in Table 5. KDIGO is a global organization founded by the National 
Kidney Foundation that provides evidence based clinical practice guidelines for kidney diseases 















Table 5. KDIGO classification of AKI. 
Acute kidney injury (AKI) can be classified into three stages based on serum creatinine and urine output. KDIGO (kidney injury: improving global 
outcomes) is a global, non-profit organization founded by National Kidney Foundation to provide guidelines for kidney diseases. 
 
AKI associated with cardiac surgery occur approximately in 8-30% of the cases. In CABG, the 
overall rates have been reported to be between 1,4% and 19,5% (Di Mauro et al. 2007). 
Preoperative renal dysfunction, hypertension and the duration of surgery are all independent risk 
factors for postoperative AKI. Chronic low glomerular filtration rate (GFR) is a sign of impaired 
renal function and is the most significant risk factor for AKI. (Zhiwei et al. 2019.) The benefit of 
off-pump surgery in terms of AKI has been studied in patients with normal and abnormal 
preoperative kidney function. A study of 1724 patients (862 OPCABG and 862 ONCABG) with 
normal preoperative renal function reported significantly higher 30-day AKI incidence in 
ONCABG arm (7,9% and 2,9%, p<0,0001). Interestingly, no benefit of OPCABG was reported in 
patients with abnormal preoperative kidney function. (Di Mauro et al. 2007.) On the other hand, a 
more recent and larger Japanese study published in 2018 showed clear association between the 
stage of preoperative renal dysfunction and incidence of postoperative renal damage requiring 
dialysis. Same study also demonstrated significant benefit of OPCABG over ONCABG regardless 
of the stage of preoperative renal dysfunction. (Ueki et al. 2018.) Since CPB seems to cause renal 
damage, shorter extracorporeal circulation time could be beneficial. In isolated ONCABG surgeries, 
an optimal cut-off time has been reported to be between 66min and 94min (Di Mauro et al. 2007, 
Zhiwei et al. 2019). 
 
4.4 Other complications 
 
According to a single-centre study of 7606 patients, intestinal ischemia is a rare but critical 
complication of CABG with an incidence of 0,4%. Acute mesenteric ischemia and its complications 
made up 7,1% of all deaths associated with CABG. The rates of acute mesenteric ischemia in 
ONCABG and OPCABG are 1,07% and 0,28%, respectively. Survival rates were 61,1% in 
OPCABG surgery and only 7,1% in ONCABG. (Soylu et al. 2019). This implicates that intestinal 
Stage Serum creatinine Urine output 
1 1,5-1,9 times baseline OR 
> 0,3mg/dl (26,5µmol/l) increase within 7 days 
<0,5ml/kg/h for 6-12 hours 
2 2,0-2,9 times baseline <0,5ml/kg/h for over 12 hours 
3 3,0 times baseline OR increase to > 4,0mg/dl (353,65µmol/l) OR 
renal replacement therapy OR estimated glomerular filtration 
rate (eGFR) <35ml/min per 1,73m2 
<0,5ml/kg/h for over 24 hours OR 






ischemia is more pronounced when CPB is used and survival after acute mesenteric ischemia is 
very unlikely.  
Another rare complication of CABG, as well as other cardiac surgery, is chylothorax (Weber et al. 
1981). Chylothorax is defined as leakage of chyle into pleural cavity. Chylothorax can have various 
etiologies including congestion, trauma and obstruction or it can happen spontaneously           
(Pêgo-Fernandes et. al 1999). Its incidence in cardiovascular surgery performed through 
thoracotomy has been reported to be between 0,25 and 0,50% (Weber et al. 1981).  
 
The rarity of chylothorax in cardiovascular surgery can be explained by the normal anatomic 
position of the thoracic duct in the upper mediastinum. It lies on the left side of the esophagus 
posterior to the arch or aorta. In the neck it ascends laterally and then turns left to descend and enter 
the left subclavian-jugular venous junction. Because of its relatively distant location to the heart, 
damage of the thoracic duct should rarely occur. However, due to anatomic variations, two or more 
tributaries occur in 40-60% of people. These branches are usually in close proximity to the origin of 
the LIMA. (Weber et al. 1981). Thus, in intrapericardial surgery, harvesting the LIMA for CABG 
through median sternotomy is the most common cause of chylothorax (Waikar et al. 2018).  
 
Surgical intervention has been recommended if the drainage exceeds 1000ml/day for several 
consecutive days (Cerfolio et al. 1996). If untreated, chylothorax can lead to severe morbidities due 




















5. SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 
Systemic inflammatory response syndrome (SIRS) is a broad and complex pathophysiological 
inflammatory reaction to various insults, such as trauma, burn or foreign particles (Balk 2014). 
SIRS was defined in Critical Care Medicine Consensus Conference in the USA in 1991 to separate 
the infectious and non-infectious inflammatory reactions from each other. SIRS is manifested by 
two or more of the following conditions: 
 
 temperature >38°C or <36°C 
 heart rate >90 beats per minute 
 respiratory rate >20 breaths per minute or PaCO2 <32 mm Hg 
 white blood cell count > 12,000/ mm³ or <4,000/ mm³, or >10% immature (band) forms 
 
For long, sepsis was defined as microbial infection with at least two of the conditions above. (Bone 
et al 1992.) This definition was in large use worldwide and remained unchanged despite the 
advances made in pathobiology, management and epidemiology during the past few decades. In 
2016, sepsis was redefined by the European Society of Intensive Care Medicine and the Society of 
Critical Care Medicine to meet the changes. Nowadays, sepsis is defined as life-threatening organ 
dysfunction caused by a dysregulated host response to infection. (Singer et al. 2016.) 
 
Surgical trauma per se is a potential trigger of inflammatory response. This is caused by tissue 
injury and foreign particles. Median sternotomy is associated with increased inflammatory response 
when compared to smaller incision made in anterolateral thoracotomy. Thus, more extensive tissue 
injury is associated with increased inflammatory response. Median sternotomy is the most common 
incision made in both OPCABG and ONCABG. Off-pump surgery eliminates the use of CPB, 
aortic cross-clamping and cardiac arrest which predispose the body to inflammatory response, 
global myocardial damage, platelet and coagulation activation and ischemia-reperfusion injury. 
Whether or not these eliminations decrease the inflammatory reactions has been controversial or at 
least the mechanisms have stayed unclear. (Gu et al. 1999.) 
 
Cytokines are polypeptides secreted by leukocytes and other cells that act on hematopoietic cells 
and activate and regulate immune and inflammatory responses (O’Shea et al. 2013). The use of 
CPB is associated with SIRS, activation of complement system and cytokine release. This can be 






circulating leukocytes intra- and postoperatively. (Czerny et al. 2000, Wan et al. 2014, Greilich et 
al. 2008.) Interleukins (IL) are a wide group of proinflammatory cytokines that have an important 
role in inflammatory response, as they act on white cell proliferation, activation, growth and 
differentiation in addition to platelet and endothelium activation (O’Shea et al. 2013).  
C-reactive protein (CRP) is an acute-phase protein synthesized by the liver and its concentration 
rises rapidly in inflammatory states. Although its use in diagnosing the cause of inflammation is 
rather unspecific, it can be used as a tool to assess early and late mortality in coronary artery bypass 
surgery. It has been shown that elevated preoperative CRP is an independent risk factor of mortality 
for patients undergoing CABG. High concentration of CRP might be an indication of an underlying 
infectious disease or inflammatory response that might stay hidden in clinical examination. High 
preoperative CRP in elective patients should be a reason for postponement whenever it is possible. 
(van Straten et al. 2009.) Behaviour of ultrasensitive CRP (US-CRP) was studied between 2012 and 
2014 in a prospective, non-randomized clinical study. Surprising results were obtained since no 
difference could be shown between OPCABG and ONCABG groups with respect to elevated     
US-CRP concentration. US-CRP was higher postoperatively when compared with preoperative 
concentrations in both groups but no statistically significant difference was found between the two 
groups. Thus, the concentration of US-CRP is not a valid tool for assessing independent 
proinflammatory effect of CPB. (Abrantes et al. 2018.) 
In CABG, serum concentration of IL-6, IL-8 and IL-10 are commonly used markers for 
inflammation, together with CRP and tumor necrosis factor alpha (TNF-α). Levels of these markers 
are elevated in both surgeries due to surgical trauma, contact with foreign surfaces and myocardial 
damage but is more significant in ONCABG which might implicate that CPB has a 
proinflammatory effect. (Czerny et al. 2000, Wan et al. 2004, Nesher et al. 2006, Meng et al. 2017.) 
In addition to cytokines and complement proteins, there are other markers to evaluate the 
inflammatory and injurious state related to CABG. High concentration of creatine kinase 
myocardial band (CK-MB) and troponin I (TnI) in blood specifically indicate myocardial injury. 
These markers start to increase soon after the induction of anaesthesia and sternotomy but remain 
similar in the beginning of CABG regardless of surgery technique. From the end of ischemia, the 
levels of CK-MB and TnI are significantly more increased in ONCABG patients up to 24 hours 
postoperatively when compared to OPCABG. Significantly increased levels of CK-MB and TnI 






Whether or not CPB is an independent risk factor for inflammatory response has been rarely 
studied. Wan et al. set up a randomized and prospective study in 2003 to elucidate the isolated 
effect of CBP on inflammation response by categorizing patients into two groups. Other group 
consisted of OPCABG and the other one of on-pump beating heart coronary artery bypass grafting 
(ON-BHCABG) patients, a hybrid technique accepted as a trade-off for subgroup of high-risk 
patients. They reported significant elevation of proinflammatory mediators in ON-BHCABG group 






















6. COAGULATION AND PLATELET ACTIVATION 
Surgical trauma per se is a potential activator of several molecular pathways, such as inflammation, 
hemostasis and endothelial function. The effect of these pathways is multidirectional: activation of 
one pathway triggers the activation of the others and vice versa. For example, thrombin, 
prothrombin, factor X and tissue factor all stimulate the synthesis of IL-6 and IL-8. (Parolari et al. 
2016.) OPCABG does not eliminate these responses and whether or not these reactions are 
decreased in off-pump surgery is still debatable. In this review, biochemical properties are 
considered less, and the focus is more on clinical approach. 
 
It was long thought that the use of CPB was the main reason for the activation of previously 
described molecular pathways. However, similar responses are activated in operations which do not 
include extracorporeal circulation, such as orthopedic and neurological surgery. This finding 
suggests that surgical trauma and operation themselves elicit endocrine and vascular stress, 
coagulation as well as pro- and anti-inflammatory responses. (Parolari et al. 2016.) 
 
Hemostatic response begins initially at the time of incision due to contact of blood with surgical 
wound and then continues when blood is circulated in a nonendothelial CPB or cell saver. 
Coagulation happens in two interrelated but separate pathways of plasmatic and cellular 
mechanisms. (Parolari et al. 2016.) A complex pathway of plasmatic activation including several 
coagulation factors in intrinsic and extrinsic pathways lead to a common coagulation pathway 
resulting in a cross-linked fibrin clot formation and thus to coagulation (Graph 1).  
 
 








Platelets play a key role in the cellular coagulation mechanism. Platelets normally travel to the 
location of vascular damage where they initially start the clotting process by aggregating and 
attaching to von Willebrand factor of endothelium and cross-linked fibrin clot with other blood 
cells. Soon after, more platelets from circulating blood are recruited by several mediators, such as 
adenosine diphosphate (ADP), thrombin and thromboxane A2 (TXA2). (Davi and Patrono 2007.) 
Vascular damage is not the only mechanism that triggers platelet activation. Similar to the 
molecular pathways of hemostasis, platelets are activated when in contact with the nonendothelial 
surface of CPB. Activation of platelets leads to a decreased formation of new platelets and platelet 
dysfunction in existing platelets. (Parolari et al. 2016.) 
 
Besides extracorporeal circulation, removal of aortic-cross clamp and administration of protamine 
right after the surgery might have pro-thrombotic affect due to possible ischemia-reperfusion injury 
and complement system activation, respectively. Such hemostatic activation bursts especially 
during the surgery and few first hours after closing of the incision. (Parolari et al. 2016.) It is well 
known that CPB triggers the coagulation pathways. Whether or not this happens solely due to use of 
CPB is unlikely. The link between CPB avoidance and reduced hemostatic response is 
contradictory and off-pump surgery could only provide limited benefit. (Parolari et al. 2016, 
Gaudino et al. 2018.) 
 
Antithrombotic drugs can be classified into two different groups by their mechanism. The first 
group targets the clotting factors of the plasma and inhibit the gamma carboxylation thus preventing 
their attachment to aggregating platelets. The other group targets the platelets by inhibiting the 
enzymatic action of cyclooxygenase and thus, prevents the synthesis of TXA2 which stimulates the 
formation and recruitment of new platelets. The balance between physiologic coagulation and 
antithrombosis after a surgery should be obtained by proper medication. The excess use of 
antithrombotic drugs predisposes to bleeding. On the other hand, medication is necessary to prevent 
formation of fatal thrombi.  
 
Oral acetylsalicylic acid (aspirin) is a commonly used peri- and postoperative antithrombotic drug 
for CABG patients. The pharmacodynamic effects of antiplatelet drugs have been examined by 
administrating low-dose aspirin either once or twice a day, both in vivo and ex vivo. (Zimmermann 
et al. 2005, Cavalca et al. 2017, Ivert et al. 2017, Paikin et al. 2017.) Unfortunately, ex vivo studies 






vivo. The capacity of platelets to excrete thromboxane A2 is up to 5000 higher in vitro when 
compared with in vivo, and hence only the latter should be taken in consideration on clinical 
implications (Davì and Patrono 2007).  
 
It seems higher doses or alternatively more frequent dosing of aspirin is associated with more 
suppressed synthesis of platelet mediators (Paikin et al. 2017). 100mg twice a day versus 100 mg or 
200mg once a day decreased the synthesis of TXA2 in vivo in a randomized trial conducted in 2016 
(Cavalca et al. 2017). Similarly, 75mg twice a day or 160mg once a day were both equally more 
effective when compared to a once-a-day dosing of 75mg (Ivert et al. 2017).  
 
The number of circulating platelets after ONCABG slightly decreases postoperatively and rapidly 
increases few days after. The increased formation of new platelets seems to compensate the 
inhibiting effect of aspirin. Within the dosing intervals, increased number of platelets are competent 
to the formation of thromboxane. Thus, CPB is associated with a phenomenon called aspirin 
resistance. (Zimmermann et al. 2005.) Although such resistance is not usually connected with 
OPCABG, the turnover of platelets is usually higher in the long run when compared to ONCABG. 



























7. SHORT-TERM OUTCOMES 
Until this day, a few large randomized controlled trials (RCT) have been conducted to compare 
early outcomes of on- and off-pump surgery. Randomized on/off bypass (ROOBY) trial was an 
American study of 2203 patients conducted at 18 Veterans affair centres in 2009. (Shroyer et al. 
2009.) No significant difference could be obtained between OPCABG and ONCABG in early 
primary end points including death, reoperation, new mechanical support, cardiac arrest, coma, 
stroke and renal failure (7,0% and 5,6%, respectively, p=0,19). A few years later a larger study was 
carried out. The CABG off- or on-pump revascularization study (CORONARY) was an 
international RCT including participants from 79 different centres in 19 countries. (Lamy et al. 
2012, Lamy et al. 2013.) Whereas high risk patients in ROOBY were excluded, CORONARY trial 
only included patients with at least one of the following risk factors: advanced age, peripheral 
arterial disease, cerebrovascular disease, carotid stenosis of 70% or more, renal insufficiency and 
LVD. In addition, surgeons had more experience than in ROOBY to minimize the impact of 
inexperience. The purpose of the trial was to study the 30-day and twelve-month outcomes 
exclusively in high-risk population undergoing CABG. Similar results were reported. Primary early 
outcomes (similar to those in ROOBY) at 30 days (9,8% for OPCABG and 10,3% for ONCABG, 
p=0,59) and at twelve months (12,1% for OPCABG and 13,3% for ONCABG, p=0,24) did not 
differ significantly. Third RCT in Germany only included first-time CABG patients over 75 years 
of age. 2539 patients were included in GOBGABE (The German off-pump coronary artery bypass 
grafting in elderly patients) study. (Diegeler et al. 2013.) Similar 30-day end point (composite of 
death, stroke, MI, repeat revascularization or new renal replacement therapy) was set for the trial. 
Despite the age of the patients, GOBGABE also failed to show any difference between the two 
techniques with respect to early adverse outcomes. Another follow-up was done after 12 months but 
the differences remained insignificant.  
Although randomized controlled trials have failed to show any difference in early outcomes in 
terms of mortality and adverse complications, some meta-analyses seem to favour off-pump 
technique when short-term outcomes are observed. A systematic review of 42 RCTs and 31 
observational studies with more than 1,2 million patients showed significant reductions (OR 0,81) 
in off-pump patients in the odds of 30-day mortality (Filardo et al. 2018). Another, smaller meta-
analysis of 35 propensity analyses and 123 137 patients also showed the short-term superiority of 
OPCABG. OR for mortality was 0,69 (p<0,0001), for stroke 0,42 (p<0,0001), for renal failure 0,60 






odds of 30-day postoperative stroke was showed in a meta-analysis of 100 studies reviewed in 2016 

























8. LONG-TERM OUTCOMES 
Late outcomes of CABG have been studied far less than those occurring shortly after the operation. 
Existing studies suggest that better short-term outcomes of OPCABG come at the expense of poorer 
long-term survival. While some studies show no difference between the two techniques with respect 
to late mortality, others show that there is a clear and significant correlation between on-pump 
surgery and long-term survival.  
 
Large RCTs could not show any significant short-term effectiveness of OPCABG. Just a few years 
ago the five-year outcomes of ROOBY and CORONARY were finally published. In December 
2016, CORONARY reported no difference in primary composite outcome of death, nonfatal MI, 
nonfatal new renal failure requiring dialysis or repeat revascularization when ONCABG and 
OPCABG were compared. (Lamy et al. 2016.) While the long-term outcomes of CORONARY 
study were similar to the short-term outcomes, ROOBY showed significant difference in primary 
outcomes (death and major adverse cardiovascular event (MACE) with death) favouring ONCABG. 
On the other hand, no significant difference was observed with respect to secondary outcomes. 
(Shroyer et al. 2017.) The five-year outcomes of CORONARY and ROOBY are listed in more 
details in Table 6 and Table 7, respectively. 
 





Hazard ratio (HR) 
(95% CI) 
p-value 
a Second co primary outcome, n (%) 548 (23,1) 560 (23,6) 0,98 (0,87 – 1,10) 0,72* 
Death 346 (14,6) 322 (13,5) 1,08 (0,93 – 1,26) 0,30* 
MI 178 (7,5) 194 (8,2) 0,92 (0,75 – 1,13) 0,41* 
Stroke 55 (2,3) 66 (2,8) 0,83 (0,58 – 1,19) 0,32* 
New renal failure requiring dialysis 40 (1,7) 45 (1,9) 0,89 (0,58 – 1,37) 0,60* 
Repeat revascularization 66 (2,8) 55 (2,3) 1,21 (0,85 – 1,73) 0,29* 
Table 6. Five-year outcomes of CABG off- or on-pump revascularization (CORONARY) study.  
a Second co primary outcome = composite of death, nonfatal stroke, nonfatal myocardial infarction (MI), nonfatal new renal failure requiring dialysis, 






















Death  168 (15,2) 131 (11,9) 1,28 (1,03 – 1,58) 0,02 
a Composite MACE with death 342 (31,0) 298 (27,1) 1,14 (1,00 – 1,30) 0,046 
Secondary outcomes 
Death from cardiac cause  70 (6,3) 58 (5,3) 1,20 (0,86 – 1,68) 0,29* 
Acute MI (nonfatal) 134 (12,1) 105 (9,6) 1,27 (1,00 – 1,62) 0,05* 
Repeat revascularization 145 (13,1) 131 (11,9) 1,10 (0,88 – 1,37) 0,39* 
b Composite MACE outcome with 
death  
270 (24,5) 234 (21,3) 1,15 (0,98 – 1,34) 0,08* 
Table 7. Five-year outcomes of Randomized on/off bypass (ROOBY) study. 
a Death from any cause, acute MI or repeat revascularization. b Death from cardiac causes, acute MI or repeat revascularization. *statistically not 
significant 
 
So far, two large meta-analysis of long-term effectiveness of OPCABG have been conducted. First 
ever large RCT-only meta-analysis considering long-term (over four-year follow-up) clinical effects 
including 8145 patients showed significantly increased mortality incidence (OR 1,16; p=0,03) in 
OPCABG population when compared to ONCABG. Surprisingly, the same meta-analysis found no 
significant difference when MI, angina pectoris, repeat revascularization and stroke were studied. 
(Smart et al. 2018.) A second, larger meta-analysis was published soon after. A study of three 
RCTs, five observational studies and 60 405 patients were included in a five-year follow-up. A risk 
ratio (RR) of 1,10 (95% CI 1,05 – 1,10) favoured on-pump technique. At ten-year follow-up, only 
one observational study was found. OPCABG was associated with an increase of 14% in terms of 
all-cause mortality. (Filardo et al. 2018.) 
 
A few retrospective, single-centre observational studies showed no difference in late survival 
between the CABG procedures (Lattouf et al. 2008, Kirmani et al. 2016). Interestingly, it has been 
proposed that long-term mortality is associated with incompleteness of revascularization rather than 
operation technique or number of grafts. The index of completeness of revascularization (ICOR) is 
the division of grafts performed by the number of diseased vessels and could predict long-term 
mortality. (Lattouf et al. 2008.) Thus, higher ICOR score predicts better long-term survival. 
 
Just like short-term outcomes, RCTs fail to show the difference or show contradictory results 
between OPCABG and ONCABG in regard to long-term outcomes. Meta-analysis of observational 












































9. FINANCIAL ASPECT AND HOSPITAL STAY 
In 2008, the direct and indirect costs of CVDs were $171,7 billion and are projected to increase to 
$275,8 billion by 2030, meaning a 61% increase in just 20 years in the USA alone. In 2009, 
416 000 inpatients underwent bypass surgery in the USA. (Roger et al. 2012.) The average cost of a 
single CABG procedure is $36 580 with no complications. Each complication related to CABG 
increase the total costs exponentially. Of these complications, prolonged ventilation of over 24 
hours (estimated cost $33 840), reoperation ($35 239) and renal failure ($33 847) increase expenses 
the most. For the past ten years, 36 588 patients underwent CABG in 18 centres in Virginia alone. 
Complications increased the medical costs by $78,6 million with prolonged ventilation being the 
highest at $59,1 million. (Mehaffey et al. 2018.) 
In comparison, between 1994 and 2013, the number of first-ever CABG patients in Finland was 
74 338 (Kiviniemi et al. 2016). As might be expected, bypass surgery is a huge expense in 
healthcare especially when funding is being lowered and at the same time the number of patients is 
rapidly increasing.  
 
The total cost of a single CABG is difficult to define and depends on many factors. In addition to 
the procedure itself, pre- and perioperative together with postoperative costs make up the total 
price. The ICU and cardiac ward stay make up most of the total costs. (Lamy et al. 2006.) Most of 
the studies have been conducted only nationwide and international comparison between the prices is 
missing since the healthcare systems differ considerably. Only one international study that consisted 
of 19 different countries was found with the search strategy used in this literature review (Lamy et 
al. 2014).  
 
Cost-effectiveness of OPCABG has been shown in several studies. The benefit of OPCABG with 
respect to total costs at discharge is considerably high and could be up to 30% (Ascione et al. 1999). 
Increased costs were found only in one study (Chu et al. 2009). Financial benefit from discharge to 
one-year follow-up also seem to favour OPCABG over ONCABG (Table 8). 
 
Within OPCABG population, advanced age, prolonged anaesthesia, use of intra-aortic balloon 
pump (IABP) and the length of preoperative hospital stay increased the medical costs due to 
increased resource use (Lamy et al. 2014, Shinjo et al. 2015). Renal failure, LVD, high 
EuroSCORE II and cerebrovascular diseases are the most expensive comorbidities (Lamy et al. 






(Lamy et al. 2014, Shinjo et al. 2015). From a financial point of view, low EF is the most important 
factor when choosing between OPCABG and ONCABG. Avoidance of CPB in this subgroup of 
patients could be up to 2,3 times more expensive ($8325 and $19 242 for ONCABG and OPCABG, 
respectively). (Lamy et al. 2014.) 
 
In high-risk patients, such as patients with diabetes, chronic obstructive pulmonary disease (COPD), 
peripheral vascular disease, cerebrovascular disease, renal dysfunction, EF < 35% or age of over 70 
years, there is no statistically significant difference with respect to total costs at 5 years and the 
choice between OPCABG and ONCABG should be rather made based on clinical risks and surgeon 
experience (Lamy et al. 2014, Wagner et al. 2019). Nevertheless, reliable studies on long-term cost-
effectiveness of OPCABG compared to ONCABG are still needed. 
 
Length of stay for CABG patients consists of pre-, peri- and postoperative stay in addition to 
follow-ups. Total hospital stay depends highly on the patient characteristic and preoperative risk 
factors, such as age, sex and severity of other comorbidities. Although operation times are usually 
longer in OPCABG (Arom et al. 1999, Nathoe et al. 2003), length of stay in ICU, cardiac ward and 
total hospital stay are shorter for OPCABG patients (Table 8) (Boyd et al. 1999, Scott et al. 2005, 
Chu et al. 2009). This applies also when there is no statistical difference in the two groups regarding 
to age, BMI, body weight, EF, IABP use, previous MIs, left main coronary artery (LMCA) disease, 



















Table 8. The differences between OPCABG and ONCABG in terms of total hospital costs at discharge, at six-month and at one-year follow-up in 











Total benefit of OPCABG Total postoperative 
length of stay 
OPCABG vs ONCABG 
Arom et 
al. 1999  
USA Retrospective 
review 












al. 1999  
Canada Retrospective, 
based on a 
database 
30 vs 60 discharge:14% decreased 
costs 
6,3 vs 7,7 
Chu et al. 
2009  
USA Retrospective, 
based on a 
database 
14 389 v 
48,658 
discharge: 2,6% increased 
costs 











Canada Propensity score 
matching 
1233 vs 1233 discharge: 14% decreased 
costs 
1 year: 15 decreased costs 
7,24 vs 8,73 
Lamy et 









discharge: 0,69% increased 
costs 
6 months: 1,0% increased 
costs 







142 vs 139 discharge: 14% decreased 
costs 








100 vs 100 discharge: 11% decreased 
costs 
1 year: 7,9 decreased costs 
 
Scott et al. 
2005 





1104 vs 1099 discharge: 1,4% increased 
costs 
1 year: 6,4 increased costs 








10. SURGEON AND HOSPITAL EXPERIENCE 
 
The operation technique on a beating heart is usually considered more demanding than in cardiac 
arrest. Surgeon experience and its effect on statistical outcomes, such as mortality, financial costs 
and length of stay, has been a subject for numerous studies. (Glance et al. 2005, Lapar et al. 2012, 
Lamy et al. 2014, Benedetto et al. 2018a, Chikwe et al. 2018.) The relative use of OPCABG has 
fluctuated for the past 20 years worldwide. In the USA, the highest peak of 21% was in 2008 before 
it declined to 17% in 2012. Ever since it has been used less frequently while PCI has gained more 
popularity. Same declining trend in the number of OPCABG procedures can be seen in high- and 
intermediate-volume centres and among high- and intermediate-volume surgeons. The use has been 
more constant in low-volume centres and among low-volume surgeons with a share of slightly less 
than 10% of all CABGs. (Bakaeen et al. 2014.) 
 
Surgeon and hospital experience play an important role in OPCABG outcomes and seem to be more 
significant when compared to conventional CABG with CBP (Lapar et al. 2012, Benedetto et al. 
2018a). A linear correlation exists between decreased mortality rates and surgeon experience. It has 
been recommended that 50 to 75 procedures are needed to acquire expertise in OPCABG (Patel et 
al. 2010). For surgeons operating more than 48 OPCABG procedures a year, the in-hospital 
mortality rates were significantly lower when compared to ONCABG (Lapar et al. 2012, Benedetto 
et al. 2018a). In a retrospective study including 999 hospitals in 44 states, 2 094 094 patients in the 
USA were reviewed from 2003 to 2011. OPCABG performed in low-volume hospitals (less than 29 
procedures a year) or by low-volume surgeons (less than 6 procedures a year) increased the        
risk-adjusted mortality significantly when compared to ONCABG. Contrary, a lower risk-adjusted 
mortality was associated with high-volume centres (over 164 procedures a year) and high-volume 
surgeons (over 48 procedures a year). (Benedetto et al. 2018a.) Although surgeon experience seems 
to be an important factor for in-hospital survival, no similar connection can be seen in the long run. 
Even high surgeon experience does not seem to improve the well-known and poor long-term 
outcomes of OPCABG. Among surgeons that had a history of over 100 OPCABG cases, a ten-year 
follow-up in terms of mortality (29,6% vs 33,4%), incomplete revascularization (8,8% vs 15,7%) 









Many studies have showed the importance of experience and volume in OPCABG with respect to 
mortality and severe complications and suggest that OPCABG should only be performed by 
experienced surgeons. Surprisingly, the vast majority (86%) of American cardiac surgeons are 
considered low-volume OPCABG surgeons performing less than 20 procedures a year. One third 
perform no OPCABG procedures at all and only one percent are in the highest third with annual 
rate of over 100 procedures. (Bakaeen et al. 2014.)  
 
Intraoperative conversion from OPCABG to ONCABG is possible and either used intendedly as 
part of the operation or unintendedly in case of an emergency. Such emergencies are usually 
arrhythmias or severe hypotension after commencement of coronary anastomoses. (Mukherjee et al. 
2012.) Overall conversion rates, undifferentiated between emergency and elective, are usually 
between 2% and 6% (Mukherjee et al. 2012, Bakaeen et al. 2014, Benedetto et al. 2018b). 
Conversion between the two techniques, especially unintended conversions, are associated with 
more adverse outcomes and increased mortality. In a trial of 1260 patients with 29 conversions 
(2,3%), the mortality rates for OPCABG converted to ONCABG compared to non-converted 
OPCABGs were 10,7% and 0,7% (P<0,001), respectively (Benedetto et al. 2018b). Similar results 
were observed in another, larger meta-analysis that included 17 studies and a total of 18 870 
patients with a conversion rate of 4,9%. Overall conversion to ONCABG increased in-hospital 
mortality by an OR of 6,18. Furthermore, emergency conversion raised the OR to 6,99. (Mukherjee 
et al. 2012.) 
 
Conversion from a beating heart to the use of CPB is more frequently used among less experienced 
surgeons. For surgeons who had experience of over 60 cases, the conversion rate was only 1,0% 
while for unexperienced surgeons with a history of one to five procedures the rate was as high as 
12,9%. (Mukherjee et al. 2012.) Given the fact that conversion is more common among 
unexperienced surgeons and the poor in-hospital outcomes that follow a conversion, OPCABG 
should be operated by experienced surgeons and unnecessary conversions should definitely be 
avoided.  
 
OPCABG procedures in high- and intermediate-volume hospitals decreased between 2008-2012 
while in low-volume hospitals the rates remained constant (Bakaeen et al. 2014). This is 






centres. (Bakaeen et al. 2014, Shinjo et al. 2015, Benedetto et al. 2018a.) The benefit of hospital 
volume, together with surgeon experience, implicate that OPCABG should be performed in 
hospitals specialized in off-pump surgery. This is, of course, highly dependent on the health care 
system in different countries. In addition to total survival rates and financial aspect, hospital 
organizational structure and its influence on short- and long-term outcomes should be studied in 






































Although there are numerous different calculators for assessing the risk for mortality, morbidities 
and other severe complications, clinical examination stays as the most important way of predicting 
a suitable operation technique for an individual. Very high-risk patients seem to gain most benefit 
of OPCABG. Such population consists of females, especially of great age. Other comorbidities 
including left ventricular dysfunction, diabetes, renal insufficiency, preoperative heart failure and 
concomitant pulmonary disease could favour OPCABG technique. 
 
Myocardial damage, atrial fibrillation, neurological complications including stroke and TIA and 
acute kidney injury are the most common and detrimental complications of coronary artery surgery. 
Although they cannot fully be eliminated by avoiding on-pump surgery, off-pump technique clearly 
diminishes some of these hazardous consequences, especially in patients with preoperative 
morbidities.   
 
In addition to previous complications, systemic inflammatory response syndrome, hypercoagulation 
and excess platelet activation are associated with CPB in numerous reports. OPCABG was initially 
invented to prevent these complications and the effect of off-pump technique on inflammation, 
hypercoagulation and platelet activation is not as clear as in ONCABG. Thus, elective bypass 
surgery should be postponed among patients with infectious or inflammatory disease and should 
rather be performed without CPB whenever surgery is urgently needed.  
 
OPCABG offers better perioperative and short-postoperative results when compared to ONCABG 
but seems to come at the expense of higher late mortality at five- and ten-year follow-up. In 
addition to operation technique, incompleteness of revascularization increases the risk for adverse 
late-term outcomes.  
 
Cardiovascular diseases and coronary artery disease are the most common cause of death in low-
income and developed countries, respectively. In general, they are a cause of huge economic burden 






has been shown in almost every study available. In addition to lower hourly theatre costs, it is 
associated with shorter total hospital stay and lesser resource use.  
 
While surgeon and hospital experience seem to be beneficial for OPCABG patients, it still plays a 
minor role when choosing between the two techniques. Although the benefit of experience in terms 
of medical costs and resource use is inevitable, risk factors and comorbidities play a more crucial 
role when it comes to complications and mortality. Thus, the choice between OPCABG and 
ONCABG on a single patient should be made on medical basis rather than financial.  
 
Increased mortality and severe complications are associated with low-volume hospitals and low-
volume surgeons. At the same time, the number of experienced surgeons is alarmingly decreasing. 
Conversion from OPCABG to ONCABG increases the risk for morbidities and mortality. 
Nevertheless, conversion is more frequent among inexperienced surgeons. These facts implicate 
that OPCABG should be centralized in high-volume hospitals with experienced off-pump surgeons 
and conversion from OPCABG to ONCABG should be avoided whenever it is possible. 
 
The debate between the two methods and their superiority compared to each other has been going 
on for decades and there seems to be no final outcome. Both techniques have their advantages and 
disadvantages. Overall, CABG is a rather safe revascularization procedure with low mortality, 
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